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Introduction:  The  present  prospective  study  compared  the  clinical  outcomes  between  a  mul-
timodal analgesia  group  and  a  patient-controlled  analgesia  (PCA)  group  for  postoperative  pain
control in  upper  extremities  surgery.
Hypothesis:  Multimodal  analgesia  including  pre-emptive  analgesic  can  provide  similar  or  supe-
rior analgesic  effects  and  a  lower  incidence  of  adverse  reactions  than  PCA  following  upper
extremity  surgery.
Patients  and  methods:  Sixty-one  patients  undergoing  upper  extremity  surgery  were  randomized
to 2  perioperative  analgesic  groups  (multimodal  analgesia  and  PCA).  We  compared  the  clini-
cal outcomes:  use  of  additional  pain  rescue,  opioid-related  complication  rate,  and  patient’s
satisfaction  between  the  2  groups.
Results:  No  signiﬁcant  differences  on  the  resting  and  exercise  pain  scores  between  the  two
groups. Also,  there  were  no  differences  regarding  additional  pain  rescue  during  postoperative
day (POD)  1,  2  and  achievement  of  rehabilitation  protocol  in  both  groups.  However,  use  of  addi-
tional pain  rescue  in  PCA  group  was  increased  signiﬁcantly  after  PCA  removal.  Moreover,  there
was signiﬁcant  difference  in  the  incidence  of  opioid-related  complications  on  operation  day  and
at POD  1.  At  discharge,  multimodal  analgesia  group  showed  signiﬁcantly  greater  satisfaction
than PCA  group.
Discussion:  Perioperative  pain  management  following  upper  extremity  surgery  through  the  mul-
an  atimodal analgesia  could  be  
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nadequate  postoperative  pain  management  has  been  corre-
ated  with  poor  functional  recovery  in  some  patients  [1], and
an  activate  a  variety  of  biologic  cascade  systems,  resulting
n  ileus,  nausea,  delayed  mobilization  and  feeding,  delayed
ospital  discharge,  and  unanticipated  hospital  readmission
2].  It  is  no  wonder  that  postoperative  pain  remains  the  most
ommon  concern  among  patients.
The  upper  extremities  are  particularly  vulnerable  to
njury,  and  thus  more  predisposed  to  surgical  treatment.
n  addition,  because  the  upper  extremities  utilize  multi-
le  joints  and  require  ﬁne  manipulation,  poor  postoperative
ehabilitation  and  a  longer  immobilization  period  can  result
n  such  complications  as  joint  stiffness  or  complex  regional
ain  syndrome,  which  negatively  impact  patients’  functional
utcomes.
A  range  of  techniques  have  been  used  to  provide  postop-
rative  analgesia,  including  non-steroidal  anti-inﬂammatory
rugs  (NSAIDs)  and  patient-controlled  analgesia  (PCA),
pidural  or  intrathecal  opioids,  and  local  anesthetic  agents.
pioids  are  considered  the  cornerstone  for  treatment  of
oderate-to-severe  acute  postoperative  pain  [3], and  PCA
s  the  most  frequent  mode  of  postoperative  opioid  admin-
stration  [4].  Although  highly  efﬁcacious,  unwanted  adverse
ffects,  such  as  ventilatory  depression,  drowsiness,  seda-
ion,  nausea,  vomiting,  pruritus,  urinary  retention,  ileus,
nd  constipation  are  frequently  observed  during  opioid  PCA
5].  Because  of  these  unwanted  adverse  effects,  PCA  is
ften  discontinued  despite  insufﬁcient  pain  management
6].  Patients  consider  nausea  and  vomiting  to  be  the  most
ndesirable  postoperative  complications  [7],  and  are  willing
o  pay  more  than  $50  to  avoid  them  [8]. Moreover,  nau-
ea  and  vomiting  delay  patients’  return  to  oral  feeding,
ecovery,  and  hospital  discharge.  Other  adverse  effects  of
pioids  similarly  impair  active  mobilization  and  rehabilita-
ion  [9].
Multimodal  analgesia,  using  a  combination  of  analgesics
hroughout  the  perioperative  period,  to  control  postopera-
ive  pain  has  become  increasingly  popular  and  well  accepted
10,11].  The  rationale  for  this  strategy  is  the  achieve-
ent  of  sufﬁcient  analgesia  caused  by  the  additive  or
ynergistic  effects  of  different  classes  of  analgesics  [12].
ultimodal  analgesia  has  been  proposed  to  decrease  opi-
id  consumption  and  to  improve  postoperative  analgesia
fter  severely  painful  surgery.  A  lower  incidence  of  adverse
ffects  and  improved  analgesia  have  been  demonstrated
ith  multimodal  analgesic  techniques,  which  may  lead  to
horter  hospitalization  times,  improved  recovery  and  func-
ion,  and  possibly  decreased  healthcare  costs  [13].  However,
tudies  on  postoperative  pain  management  via  multimodal
nalgesia  have  been  limited  to  hip  and  knee  arthroplasty,
pine  surgery,  or  major  operations  such  as  cardiac,  abdom-
nal,  or  cancer  surgery.  Few  studies  have  been  conducted
n  postoperative  pain  management  of  the  upper  extremi-
ies.
The  present  working  hypothesis  was  that  multimodal
nalgesia  including  pre-emptive  analgesic  can  provide  simi-
ar  analgesic  effects  and  a  lower  incidence  of  adverse  effects
han  PCA,  and  this  method  has  similar  clinical  outcomes  as
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 clinical  outcomes;
 complication  rate;
 administration  of  additional  pain  rescue;
 patient  satisfaction.
atients and methods
e  prospectively  compared  the  intensity  of  pain  (inde-
endent  evaluator)  for  principal  evaluation  criteria,
nd  functional  outcome  (Mayo  Elbow  Performance  Score
MEPS]),  complication  of  opioids  and  multimodal  analgesic
rugs  and  patient  satisfaction  for  secondary  evaluation
riteria  between  a  group  of  patients  who  received  mul-
imodal  analgesia  including  pre-emptive  analgesics  and  a
roup  of  patients  who  used  PCA  for  postoperative  pain  con-
rol  from  February2009  to  October  2011.
atients  and  evaluations
mong  upper  extremity  surgeries,  those  around  the  elbow,
hich  are  associated  with  relatively  more  severe  periopera-
ive  pain  and  require  early  rehabilitation,  were  selected  for
he  comparison  of  patients  with  the  same  conditions  in  this
tudy.  The  inclusion  criteria  were  as  follows:
 fracture  around  the  elbow  and  dislocation,  multiple  elbow
ligament  injuries,  or  severe  osteoarthritis  (OA)  of  the
elbow,  which  was  treated  with  ulno-humeral  arthroplasty
or  total  elbow  arthroplasty;
 ability  to  undergo  axillary  brachial  plexus  block  (BPB);
 no  neurologic  symptoms  involving  the  upper  extremities;
 normal  upper  extremity  function  before  injury.
The  exclusion  criteria  included  the  following:  renal  insuf-
ciency;  severe  systemic  arthritis;  rheumatoid  arthritis;
iabetes  with  signiﬁcant  peripheral  neuropathy;  contraindi-
ations  (e.g.,  localized  infection,  sepsis,  or  pre-existing
eurologic  abnormality  involving  the  upper  extremities);
atient  refusal  of  either  BPB  or  IV-PCA;  allergy  to
ocal  anesthetics,  morphine,  or  oxycodone;  chronic  opi-
id  use;  multiple  traumas;  pathologic  fracture;  history
f  PCA  discontinuation  due  to  adverse  effects;  and  difﬁ-
ulty  comprehending  the  VAS  or  how  to  use  the  IV-PCA
evice.
A  total  of  63  patients  were  selected  initially,  but  2  were
xcluded  because  of  inadequate  BPB  anesthesia,  with  a
onversion  to  general  anesthesia  intraoperatively  (1each  in
roups,  A  and  B).  Therefore,  61  patients  comprising  of  37
omen  and  24  men,  with  a mean  age  of  53  years  (range,
1—78  years)  were  enrolled  in  this  study.  Their  demo-
raphics  and  general  medical  information  were  obtained
Table  1).The  clinical  pathway  and  randomization  process
ere  explained.  The  patients  were  randomized  into  2  groups
sing  a  computer-generated  random  number  and  a  sealed
nvelope  design:  group  A  (n  =  30)  received  multimodal  anal-
esia  including  pre-emptive  analgesics  (cyclooxygenase-2
COX-2)  inhibitor,  pregabalin,  and  NSAIDs  orally),  whereas
roup  B  (n  =  31)  received  IV-PCA  postoperatively,  without
re-emptive  analgesics.
Multimodal  analgesia  for  upper  extremity  surgery  
Table  1  Demographics  and  general  medical  information.
Variables  Group  A  Group  B
Patients  (n)  30  31
Injury type  (n)
Distal  humerus  fracture  19  21
Elbow fracture  and  dislocation  5  5
Multiple  elbow  ligament  injuries  1  2
Osteoarthritis  5  3
Gender  (M/F) 13/17  11/20
Age (years) 52.3  (10) 54.1  (11)
Height  (cm)  169.3  (11)  168.7  (9)

































ABody Mass  Index  (kg/m )  24  (3)  25  (3)
Values are mean (±SD).
Analgesic  management
Various  regimens  of  multimodal  analgesia  including  pre-
emptive  analgesics  have  been  introduced  [14,15].  Common
medications  include  NSAIDs,  COX-2  inhibitor,  ketamine,  local
anesthetics,  2-agonist,  and  2-ligands  [16].  The  current
pain  management  regimen  at  our  hospital  utilizes  some  of
these  available  agents  [17].  One  hour  before  surgery,  when
patient  was  called  into  the  operating  room,  the  patients
in  group  A  received  pre-emptive  treatment  with  NSAIDs
(ibuprofen  800  mg),  COX-2  inhibitor  (celecoxib  400  mg),  pre-
gabalin  75  mg  with  a  little  water.
All  patients  were  operated  under  BPB  anesthesia  admin-
istered  by  a  senior  anesthetist.  Before  incision  and  after
skin  closure,  the  skin,  subcutaneous  tissues,  and  periosteum
of  incision  site  in  all  patients  were  injected  with  a  40  mL
mixture  of  normal  saline  450  mL,  0.75%  ropivacaine  40  mL,
ketorolac  30  mg,  and  epinephrine  0.5  mg.
The  patients  in  groupA  received  ibuprofen  800  mg,  cele-
coxib  400  mg,  and  pregabalin  75  mg  2  hours  after  the  surgery.
From  postoperative  day  (POD)  1,  the  patient  in  group  A
received  this  same  regimen  twice  daily  for  2  weeks.  Whereas





Table  2  Protocols  for  postoperative  pain  management  in  group  A
Period  Group  A  Group  B  
Pre-emptive  Ibuprofen  800  mg
Celecoxib  400  mg
Pregabalin  75  mg
—  
Operation day  Ibuprofen  800  mg
Celecoxib  400  mg
Pregabalin  75  mg




POD 1—3  Ibuprofen  800  mg
Celecoxib  200  mg
Pregabalin  75  mg
twice  daily
IV-PCA  
POD 3—7  Same  as  above  —  
POD 7—14  Same  as  above  —  
POD: postoperative day; IV: intravenous; PCA: patient controlled analg897
his  was  initiated  in  the  recovery  room.  IV-PCA  (butor-
hanol4  mg,  ketorolac  150  mg,  and  normal  saline  50  mL),
hich  was  programmed  to  deliver  a  1  mg  bolus  (lock-out  of
0  min)  with  a  maximum  dose  of  6  mg/h,  was  available  to  all
he  patients  in  group  B,  who  were  instructed  to  titrate  their
AS  pain  scores  to  ≤  3  out  of  10  until  the  morning  of  POD  3.
n  POD  3,  IVPCA  was  discontinued.  All  the  patients  in  groups
 and  B  received  oxycodone  hydrochloride  (HCl)  10  mg  every
2  hours  and  acetaminophen  650  mg  3  times  daily  postop-
ratively  (oxycodone  HCl  for  1  week,  acetaminophen  for
 weeks).  Any  breakthrough  pain  (deﬁned  as  ≥  4/10  on
he  VAS)  after  surgery  was  controlled  on  demand  with  IV
aracetamol  2  gadministered  4  times  daily  and  additional
xycodone  HCL  10  mg  administered  every  12  hours  in  both
he  groups  (Table  2).
ehabilitation
 scheduled  range  of  motion  (ROM)  exercise  rehabilitation
rotocol  was  set  for  elbow  ROM  after  surgery  in  both  the
roups.  Rehabilitation  following  elbow  surgery  follows  a
equential  and  progressive  multiphased  approach  consist-
ng  of  an  immediate  motion  phase  (week  1),  intermediate
hase  (weeks  2—4),  advanced  strengthening  phase  (weeks
—8),  and  return-to-activity  phase  (weeks  8—12)  (Table  3)
18—20]. Elbow  ROM  exercises  are  initiated  as  tolerated  the
ay  after  surgery  under  the  supervision  of  a  physiotherapist.
he  patients  were  discharged  after  a  2-week  hospitaliza-
ion,  and  then  followed-up  at  4,  8,  and  12  weeks  to  examine
heir  achievement.  Subsequently,  patients  were  trained  on
he  subsequent  protocol  and  preceded  to  the  next  phase.
fter  6  months,  the  physiotherapist  evaluated  the  functional
utcomes  of  the  elbow  of  all  the  patients.
ssessmentshe  intensity  of  postoperative  pain  was  assessed  using  the
00-mm  VAS  pain  scale  ruler,  which  ranged  from  0  (no
ain)  to  100  (worst  pain  imaginable).  A  single  evaluator,
ho  was  not  involved  in  and  unaware  of  the  concepts  and
 and  B.
Common  As  required
—  —
Oxycodone  HCl  10  mg
every  12  hours
Acetaminophen  650  mg
3  times  daily
IV  paracetamol  2  g
Oxycodone
HCL  10  mg
Same  as  above  Same  as  above
Same  as  above  Same  as  above
Acetaminophen  650  mg
3  times  daily
Same  as  above
esia; HCl: hydrochloride.
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Table  3  Scheduled  ROM  exercise  rehabilitation  protocol.
Immediate  motion  phase  (week  1)
Goals:  full  wrist  and  elbow  ROM,  decrease  swelling
POD  2
Remove  bulky  dressing  and  replace  with  elastic  bandages
Immediate  hand,  wrist,  and  elbow  exercises
Grip strengthening
Wrist  ﬂexor  and  extensor  stretching
Pronation/supination
POD  3  to  7
Passive  ROM  elbow  extension/ﬂexion  (motion  to  tolerance)
Begin  progressive  resisted  exercises  (PRE)
Intermediate  phase  (weeks  2—4)
Goals:  improve  muscular  strength  and  endurance,  normalize  joint  arthrokinematics
Week 2
ROM  exercises  (overpressure  into  extension)
Continue  to  progress  PRE  weight  and  repetitions  as  tolerable
Week 3
Initiate  biceps  and  biceps  eccentric  exercise  program
Initiate  rotator  cuff  exercises  program
Advanced  strengthening  phase  (weeks  4—8)
Goals:  gradually  increase  strength,  power,  endurance,  and  neuromuscular  control  in  order  to  prepare  for  a  gradual  return  to
sport
Weeks 4—6
Aggressive  strengthening  exercises,  emphasizing  high  speed  and  eccentric  contraction
Resistance  applied  for  concentric  and  eccentric  contractions  of  the  elbow  ﬂexors
Aggressive  strengthening  exercises  with  weight  machines
Weeks  7—8
Neuromuscular  control  exercises  progress
Initiate  plyometric  exercises  program
Return-to-activity  phase  (weeks  8—12)
Goal:  progressively  return  to  full  competition  sport  activities
Exhibit  full  ROM  with  no  pain  or  tenderness































mROM range of motion, POD postoperative day.
ethod  of  this  study,  determined  the  VAS  score  for  each
atient.  On  operation  day,  the  VAS  score  was  recorded  at
 and  12  hours  after  surgery.  From  POD  1,  the  resting  pain
core  was  measured  at  9:00  and  18:00  for  resting,  and
rom  POD  2,  when  ROM  exercise  was  initiated,  the  exer-
ise  pain  score  was  measured  at  11:00  and  20:00.  We  used
he  average  of  the  VAS  measurements  each  for  resting  and
xercise.  Achievement  of  ROM  exercise  was  measured  by
 blinded,  independent  physiotherapist.  Once  the  patient
nitiated  ROM  exercise  according  to  the  scheduled  ROM
xercise  rehabilitation  protocol  on  POD  2,  the  physiother-
pist  assessed  when  the  scheduled  ROM  exercise  could  be
onducted  by  the  patient,  and  whether  additional  pain  res-
ue  was  required  to  conduct  the  scheduled  ROM  exercise.
n  addition,  after  the  6-month  follow-up,  the  physiothera-
ist  evaluated  the  functional  outcomes  of  the  elbow.  The
unctional  outcomes  were  assessed  using  the  MEPS  [21].
n  the  MEPS  system,  pain  (45  points),  motion  (20  points),
o
t
ttability  (10  points)  and  function  (25  points)  were  evaluated.
he  ROM  of  the  elbow  was  evaluated  using  a  goniometer.  The
unctional  arc  of  ﬂexion—extension,  as  determined  based
n  a  ﬂexion—extension  arc  of  30◦ to  130◦, and  100◦ of  fore-
rm  rotation  [22], and  the  range  of  pronation  and  supination
ere  evaluated  with  the  elbow  ﬂexed  90◦,  and  compared
ith  the  range  of  motion  of  the  contralateral  side  (as  a
ercentage).
The  complicationsof  opioids  and  multimodal  analgesic
rugs  were  noted  as  present  or  absent,  according  to  the  use
f  medication.  The  following  were  recorded:  postoperative
ausea  or  vomiting  requiring  antiemetic  drugs,  constipation
equiring  laxatives,  urinary  retention  requiring  the  place-
ent  of  a  catheter,  and  drowsiness  when  normal  activities
r  physiotherapy  could  not  occur  because  the  patient  was
oo  sleepy.
Patient  satisfaction  with  the  analgesia  was  assessed  on
he  day  of  discharge  using  a  4-point  scale:  insufﬁcient,  4
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Figure  1  Graph  display  the  resting  pain  scores  from  6  hours
after the  operation  to  post-operation  day  14.  The  values  are
Figure  2  Graph  display  the  exercise  pain  scores  from  post-
operation  day  (POD)  2  to  PODs14.  The  values  are  expressed  as
the mean  (SD).  There  were  no  signiﬁcant  differences  between
the 2  groups  (P  >  0.05).
Figure  3  Graph  display  the  achievement  of  scheduled  range
of motion  (ROM)  exercise  (bar  graph)  from  post-operation  day
(POD) 2  to  POD  14,  as  well  as  the  administration  of  additional
pain  rescue  (line  graph)  from  operation  day  to  POD  7.  The  val-
ues are  expressed  as  the  percentage  of  patients.  There  were
no signiﬁcant  differences  between  the  2  groups  (P  >  0.05),  with
regard to  the  achievement  of  scheduled  ROM  exercise.  However,











iexpressed  as  the  mean  (SD).  There  were  no  signiﬁcant  differ-
ences between  the  2  groups  (P  >  0.05).
points;  satisfactory,  3  points;  good,  2  points;  or  very  good,
1  point.
Statistics
The  differences  between  the2  groups  were  assessed  using
the  Wilcoxon  signed-rank  test  for  pain  score,  functional  out-
comes  of  the  elbow,  and  patient  satisfaction,  and  Fisher’s
exact  test  for  complications,  achievement  of  scheduled
ROM  exercise,  and  administration  of  additional  pain  rescue.
Statistical  analysis  was  performed  using  SPSS  version  20.0
software  (IBM  Corporation,  Armonk,  NY).  A  P-value  of  <  0.05
was  considered  statistically  signiﬁcant.
Results
The  resting  pain  scores  of  group  A  were  lower  than  those  of
group  B,  there  was  no  signiﬁcant  difference  between  the  2
groups  (P  =  0.655,  0.089,  0.597,  0.783,  0.988,  0.692,  0.785,
0.942,  0.992  at  6  and  12  hours  after  surgery,  and  on  PODs  1  to
14,  respectively)  (Fig.  1).  In  group  A,  the  exercise  pain  scores
gradually  decreased  as  time  passed.  Meanwhile,  in  group  B,
they  smoothly  decreased  upon  PCA  removal  on  POD  3,  and
gradually  decreased  thereafter.  Although  the  exercise  pain
scores  of  group  B  were  higher  than  those  of  group  A,  the
difference  was  not  statistically  signiﬁcant  (P  =  0.068,  0.623,
0.598  at  PODs  3  to5,  respectively)  (Fig.  2).
No  signiﬁcant  difference  in  additional  pain  rescue  was
found  between  the  2  groups  on  operation  day,  POD  1  and
2  (P  =  0.73,  >0.99,  >0.99,  respectively).  However,  the  addi-
tional  pain  rescue  increased  signiﬁcantly  in  group  B  after
PCA  removal  (P  =  0.014  and  0.012  on  PODs  3  and  4,  respec-
tively).  No  difference  in  the  achievement  of  rehabilitation
protocol  was  observed  between  the  2  groups  (P  >  0.99)
(Fig.  3).  There  was  a  signiﬁcant  difference  in  the  incidence
of  opioid-related  complications  on  operation  day  and  POD  1
(P  =  0.018  and  0.037,  respectively)  (Fig.  4).Complications  of  multimodal  analgesic  drugs  (pregabalin,
NSAIDs),  such  as  headache,  dizziness,  and  somnolence  were
not  reported  by  any  patients  in  group  A.  At  discharge,




fdditional  pain  rescue  on  PODs  3  and  4  (P  =  0.014  and  0.012,
espectively).  Op:  operation; *:  statistically  signiﬁcant.
atisfaction  with  their  method  of  analgesia  than  the  patients
n  group  B  (P  =  0.001):  group  B  scored  2.0  (range,  2.0—3.0),
hereas  group  A  scored  1.0  (range,  1.0—2.0).
The  functional  outcomes  were  measured  at  6-month
ollow-up.  The  functional  outcomes  were  similar  in  the  2
roups  (P  >  0.99)  (Table  4).
iscussion
he  results  of  this  study  showed  that  the  opioid-related
omplication  rate  was  signiﬁcantly  lower  in  group  A  than
n  group  B  on  operation  day  and  POD  1.  In  particular,  the
reatment  was  effective  in  reducing  postoperative  nausea
nd  vomiting,  which  tend  to  be  severest  on  operation  day
nd  POD  1  [9],  and  most  signiﬁcantly  affect  patient  satis-
action  [7].  In  most  previous  studies,  no  limit  was  set  to  the
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Table  4  Functional  outcomes  at  6  months  follow-up.
Injury  type  Group  A  Group  B  P-value
Distal  humerus  fracture  ﬂex-ext:  122  ±  7◦ ﬂex-ext:  125  ±  11◦ >0.99
pro/sup:  158  ±  10◦ pro/sup:  154  ±  7◦ >0.99
MEPS: 88  ±  8.4  MEPS:  85  ±  5.4  >0.99
Elbow fracture  and  dislocation  ﬂex-ext:  121  ±  11◦ ﬂex-ext:  122  ±  9◦ >0.99
pro/sup:  153  ±  7◦ pro/sup:  155  ±  6◦ >0.99
MEPS: 90  ±  7.4  MEPS:  88  ±  8.4  >0.99
Multiple elbow  ligament  injury ﬂex-ext:  127  ±  6◦ ﬂex-ext:  124  ±  9◦ >0.99
pro/sup:  159  ±  5◦ pro/sup:  158  ±  9◦ >0.99
MEPS: 90  ±  5.2 MEPS:  89  ±  7.9 >0.99
Osteoarthritis  ﬂex-ext:  135  ±  14◦ ﬂex-ext:  133  ±  12◦ >0.99
pro/sup:  146  ±  11◦ pro/sup:  148  ±  8◦ >0.99
MEPS: 85  ±  8.8  MEPS:  87  ±  8.6  >0.99
Values are mean (±SD); ﬂex: ﬂexion; ext: extension; pro: pronation; s
Figure  4  Graph  display  the  opioid-related  complication  rate
from operation  day  to  postoperative  (POD)  4.  The  values  are
expressed  as  the  percentage  of  patients  and  the  number  of
patients  in  detail.  Patients  in  group  B  reported  signiﬁcantly
more  opioid-related  complications  on  operation  day  and  POD  1























































fons: constipation;  UR:  urinary  retention;  drow:  drowsiness; *:
tatistically  signiﬁcant.
ose  of  opioids  administered  of  PCA  system  [9].  Although
he  IV-PCA  system  used  in  this  study  had  a  bolus  dose  of
 mg,  a  lock-out  interval  of  10  min,  and  a  maximum  dose
f  6  mg/h,  44%  of  the  patients  reported  adverse  effects.
he  multimodal  analgesia  used  in  this  study  signiﬁcantly
ecreased  opioid-related  complications.  Furthermore,  we
bserved  no  signiﬁcant  difference  in  the  postoperative  anal-
esic  effect  in  both  groups.  IV-PCA  can  be  used  in  the
ecovery  room  immediately  following  surgery.  In  addition,
edication  can  be  continued  during  the  use  of  IV-PCA,  and
f  desired  by  a  patient,  immediate  pain  management  can  be
chieved  via  bolus  dose.  However,  unlike  multimodal  anal-
esia,  which  enables  constant  pain  control  for  2  weeks,
V-PCA  is  removed  on  POD  2  or  3,  if  postoperative  pain
ecreases.
Pain  evaluation  generally  is  performed  in  a  resting  state
ith  the  use  of  the  VAS.  However,  this  evaluation  does
ot  consider  unexpected  peaks  in  pain  that  occur  after




pup: supination; MEPS: Mayo Elbow Performance Score.
OM  exercise,  and  this  pain  can  increase  their  fear  and
ecrease  their  motivation  for  ROM  exercise,  leading  to
oor  postoperative  clinical  outcome  caused  by  improper
OM  exercise.  As  shown  in  this  study,  the  removal  of  IV-
CA  on  POD  3  did  not  affect  the  resting  pain  scores,  but
id  affect  the  exercise  pain  scores.  After  the  removal
f  IV-PCA,  the  administration  of  additional  pain  rescues
ncreased  signiﬁcantly  required  in  group  B.  Furthermore,
he  achievement  of  scheduled  ROM  exercise  was  similar
etween  the  2  groups  during  their  2-week  hospitaliza-
ion.  This  means  that  more  additional  pain  rescue  was
equired  in  group  B  to  obtain  the  similar  clinical  outcomes  of
roup  A.
There  were  as  few  limitations  of  this  study.  First,  the
harmacokinetics  and  effective  dose  of  multimodal  anal-
esia  were  not  determined.  Therefore,  outcomes  may  vary
epending  on  the  regimen  utilized.  Second,  unlike  IV-PCA,
ultimodal  analgesia  including  pre-emptive  analgesics  has
he  disadvantage  of  having  to  administer  medication  at  a
xed  time.  If  patient  compliance  is  low,  it  can  cause  poor
ain  management  due  to  a  difference  in  medication  time
nd  dose.  Third,  the  subjects  of  this  study  were  restricted  to
atients  who  could  undergo  axillary  BPB.  The  residual  effect
f  BPB  could  affect  acute  postoperative  pain.  Besides,  in  the
ase  of  general  anesthesia,  perioperative  pain  management
ould  be  difﬁcult  as  medication  is  unavailable  for  fasting
eriod.
onclusion
n  surgery  associated  with  intense  postoperative  pain,
uccessful  postoperative  pain  management  is  difﬁcult
o  achieve  without  the  PCA,  despite  its  complications.
owever,  we  found  that  multimodal  analgesia  including  pre-
mptive  analgesics  for  perioperative  pain  management  in
pper  extremity  surgery  had  a  lower  complication  rate  and
dditional  pain  rescue,  and  had  similar  analgesic  effects  and
unctional  outcomes,  compared  with  IV-PCA.  As  shown  in
his  study,  multimodal  analgesia  including  pre-emptive  anal-
esics  can  be  useful  and  an  acceptable  alternative  in  upper
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